Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News Alert: US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

News You Need to Know Today
News Alert: US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk
Tuesday, April 13, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 

READ MORE >
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.
Share on Twitter Share on Facebook Share on Linkedin

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.
The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: FDA's alert about J&J heart pumps | $71M in fraud | A new obstacle for heart patients | Lead approved for LBBAP
The long-term impact of hypertension during pregnancy | Heart disease, stroke on the rise among women | CCTA delivers value
Vascular imaging at heart of $71M fraud scheme | Planning before TAVR | FDA clears platform | Whole-body MRI provider adds CCTA
It’s getting harder for heart patients to seek help | New PE guidelines | What cardiologists need to know about Lp(a)
FDA shares heart pump warning | Women face rising cardiovascular risks | Alcohol use & CLTI outcomes | 20-year PFO closure data
Reprocessed medical devices recalled | CGM sensor issue linked to 860 serious injuries | Managing patients with high-risk leads
Potential downsides to AI | Surgery bests GLP-1 drugs | MiniMed seeks $7.9B valuation | AHA launches women's health initiative

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …20
    • Page 21
    • Page 22
    • Page 23
    • Current page 24
    • Page 25
    • Page 26
    • Page 27
    • Page 28 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme